{"id":147867,"date":"2023-05-31T07:41:31","date_gmt":"2023-05-31T11:41:31","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147867"},"modified":"2023-05-31T07:41:32","modified_gmt":"2023-05-31T11:41:32","slug":"jubilant-pharmova-q4fy23-reported-losses","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-q4fy23-reported-losses\/","title":{"rendered":"Jubilant Pharmova Q4FY23; Reported Losses"},"content":{"rendered":"\n<p>Jubilant Pharmova Ltd.\u2019s revenue in Q4FY23 rose 10% to \u20b9 1,678 crores. Consolidated Loss After Tax came at \u20b9 101 crores in Q4FY23.<\/p>\n\n\n\n<div class=\"wp-block-image is-style-default\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA.jpg\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"840\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA-840x1024.jpg\" alt=\"\" class=\"wp-image-147869\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA-840x1024.jpg 840w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA-246x300.jpg 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA-768x936.jpg 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA-1260x1536.jpg 1260w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Q4FY23-JUBLPHARMA.jpg 1280w\" sizes=\"auto, (max-width: 840px) 100vw, 840px\" \/><\/a><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Jubilant Pharmova Ltd.\u2019s revenue in Q4FY23 rose 10% to \u20b9 1,678 crores. Consolidated Loss After Tax came at \u20b9 101 crores in Q4FY23.<\/p>\n","protected":false},"author":1885,"featured_media":134978,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[12142],"class_list":["post-147867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-healthcare-stocks","tag-radiopharma"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":147963,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-q4fy23-earnings-story\/","url_meta":{"origin":147867,"position":0},"title":"Jubilant Pharmova Q4FY23 Earnings Story","author":"Karan_Singh","date":"June 1, 2023","format":false,"excerpt":"The three business components of Jubilant Pharmova Ltd, which include medicines, contract research and development services, and patented new therapies, make up this integrated global pharmaceuticals corporation. Financial Results: Jubilant Pharmova Ltd. reported Total Income for Q4FY23 of \u20b9 1,683 Crores up from \u20b9 1,525 Crore year on year, a\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":166648,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q3fy25-53-rise-in-profits\/","url_meta":{"origin":147867,"position":1},"title":"Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits","author":"Chirag Gupta","date":"February 4, 2025","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q3FY25 of \u20b91,822.00 Crores up from \u20b91,677.00 Crore year on year, a rise of 8.65%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168645,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q4fy25-10-rise-in-revenue\/","url_meta":{"origin":147867,"position":2},"title":"Jubilant Pharmova Ltd Q4FY25; 10% rise in Revenue","author":"Chirag Gupta","date":"June 4, 2025","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q4FY25 of \u20b91,929.00 Crores up from \u20b91,759.00 Crore year on year, a rise of 9.66%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155635,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q2fy24-1140-rise-in-profits\/","url_meta":{"origin":147867,"position":3},"title":"Jubilant Pharmova Ltd Q2FY24; 1140% rise in Profits","author":"Hardik Bhandare","date":"November 1, 2023","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q2FY24 of \u20b91,680.00 Crores up from \u20b91,600.00 Crore year on year, a rise of 5.0%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-16.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165380,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q2fy25-65-rise-in-profits\/","url_meta":{"origin":147867,"position":4},"title":"Jubilant Pharmova Ltd Q2FY25; 65% rise in Profits","author":"Chirag Gupta","date":"November 4, 2024","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q2FY25 of \u20b91,752.00 Crores up from \u20b91,680.00 Crore year on year, a rise of 4.29%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161673,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-ltd-q4fy24-5-rise-in-revenue\/","url_meta":{"origin":147867,"position":5},"title":"Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue","author":"Chirag Gupta","date":"May 29, 2024","format":false,"excerpt":"Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs. Financial Results: Jubilant Pharmova Ltd reported Revenues for Q4FY24 of \u20b91,759.00 Crores up from \u20b91,678.00 Crore year on year, a rise of 4.83%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-212.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147867"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147867\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/134978"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}